Andreas Penk - Articles and news items

Pfizer logo

Pfizer’s BOSULIF® (bosutinib) receives conditional marketing authorization from the European Commission

Industry news, News / 28 March 2013 / Pfizer

“I’m delighted the EC has approved BOSULIF…”

Pfizer logo

Pfizer’s XALKORI® receives conditional marketing authorization from the European Commission

Industry news, News / 24 October 2012 / Pfizer

Conditional marketing authorization for XALKORI® in the EU granted…

Pfizer logo

Pfizer receives EU Marketing Authorization for INLYTA®(Axitinib)

Industry news, News / 4 September 2012 / Pfizer

The European Commission has granted marketing authorization for INLYTA® (axitinib)…

Pfizer logo

Pfizer announces EMA acceptance of regulatory submissions for two investigational cancer therapies

Industry news, News / 17 August 2011 / Pfizer

EMA accepted Pfizer’s regulatory submissions for review of two investigational compounds…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+